In a physiological setting, IGF-1 inhibits apoptotic effects and supports cell survival, whereas, in pathophysiological conditions, IGF-1 can enhance cancer progression or increase the number of adipocytes [30,31,32,33,34]. The gene discussed is IGF1; the disease is cancer.